With the lifting of sanctions, many announced their readiness to work with “Actoverco
We have a program for production of Rituximab and Bevacizumab drugs for cancer patients, ophthalmologists, etc. These drugs are very expensive due to their high technical knowledge, and from next year, we will also produce the raw materials for these drugs ourselves.
We have a program for production of Rituximab and Bevacizumab drugs for cancer patients, ophthalmologists, etc. These drugs are very expensive due to their high technical knowledge, and from next year, we will also produce the raw materials for these drugs ourselves.
Dr. Mostofi, the CEO of factory, during the visit of the German economic delegation as one of the most reputable pharmaceutical companies in the country, said: “Actoverco is the official representative of 6 world-class pharmaceutical companies and during 40 years these companies trusted Actoverco to enter the dynamic market of Iran. Said a nationwide drug.”
According to the public relations of Actover Group, Dr. Reza Mostofi, in an interview with reporters, by referring to the activities of Actoverco Company, stated: “Currently, we have a wide range of drugs in our company’s product portfolio. At first, we started our work with the production of oral drugs and moved on toward the production of injectable drugs. Accordingly, the production of biological drugs has been on the company’s agenda.
Related Links :
